LUMELung1_3C | R Documentation |
Kaplan-Meier digitized data from LUMELung1, figure 3C (PMID 24411639). A reported sample size of 655 for a primary endpoint of PFS in lung cancer.
LUMELung1_3C
A data frame of 1,314 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (docetaxel_nintedanib, docetaxel_placebo) | |
Reck M, Kaiser R, Mellemgaard A, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 2014; 15: 143–55.
summary(LUMELung1_3C)
kmplot(LUMELung1_3C)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.